| Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children A Drilon, TW Laetsch, S Kummar, SG DuBois, UN Lassen, GD Demetri, ... New England Journal of Medicine 378 (8), 731-739, 2018 | 2529 | 2018 |
| Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors JF Shern, L Chen, J Chmielecki, JS Wei, R Patidar, M Rosenberg, ... Cancer discovery 4 (2), 216-231, 2014 | 703 | 2014 |
| Ewing sarcoma: current management and future approaches through collaboration N Gaspar, DS Hawkins, U Dirksen, IJ Lewis, S Ferrari, MC Le Deley, ... J Clin Oncol 33 (27), 3036-3046, 2015 | 701 | 2015 |
| Rhabdomyosarcoma SX Skapek, A Ferrari, AA Gupta, PJ Lupo, E Butler, J Shipley, FG Barr, ... Nature reviews disease primers 5 (1), 1, 2019 | 514 | 2019 |
| Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study TW Laetsch, SG DuBois, L Mascarenhas, B Turpin, N Federman, ... The Lancet Oncology 19 (5), 705-714, 2018 | 514 | 2018 |
| Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort S Smeland, SS Bielack, J Whelan, M Bernstein, P Hogendoorn, MD Krailo, ... European journal of cancer 109, 36-50, 2019 | 486 | 2019 |
| Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label … NM Marina, S Smeland, SS Bielack, M Bernstein, G Jovic, MD Krailo, ... The Lancet Oncology 17 (10), 1396-1408, 2016 | 484 | 2016 |
| Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents DS Hawkins, GW Demers, DA Galloway Cancer research 56 (4), 892-898, 1996 | 442 | 1996 |
| Rhabdomyosarcoma: review of the Children's Oncology Group (COG) Soft‐Tissue Sarcoma Committee experience and rationale for current COG studies S Malempati, DS Hawkins Pediatric blood & cancer 59 (1), 5-10, 2012 | 435 | 2012 |
| Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for … CAS Arndt, JA Stoner, DS Hawkins, DA Rodeberg, AA Hayes-Jordan, ... Journal of Clinical Oncology 27 (31), 5182, 2009 | 376 | 2009 |
| [18F]Fluorodeoxyglucose Positron Emission Tomography Predicts Outcome for Ewing Sarcoma Family of Tumors DS Hawkins, SM Schuetze, JE Butrynski, JG Rajendran, CB Vernon, ... Journal of Clinical Oncology 23 (34), 8828-8834, 2005 | 334 | 2005 |
| Targeting oxidative stress in embryonal rhabdomyosarcoma X Chen, E Stewart, AA Shelat, C Qu, A Bahrami, M Hatley, G Wu, ... Cancer cell 24 (6), 710-724, 2013 | 323 | 2013 |
| Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group AS Pappo, JR Anderson, WM Crist, MD Wharam, PP Breitfeld, D Hawkins, ... Journal of Clinical Oncology 17 (11), 3487-3493, 1999 | 310 | 1999 |
| Genome-informed targeted therapy for osteosarcoma LC Sayles, MR Breese, AL Koehne, SG Leung, AG Lee, HY Liu, ... Cancer discovery 9 (1), 46-63, 2019 | 301 | 2019 |
| Evaluation of chemotherapy response in pediatric bone sarcomas by [F‐18]‐fluorodeoxy‐D‐glucose positron emission tomography DS Hawkins, JG Rajendran, EU Conrad III, JD Bruckner, JF Eary Cancer 94 (12), 3277-3284, 2002 | 292 | 2002 |
| PAX‐FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: A children's oncology group report SX Skapek, J Anderson, FG Barr, JA Bridge, JM Gastier‐Foster, ... Pediatric blood & cancer 60 (9), 1411-1417, 2013 | 262 | 2013 |
| Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy SM Schuetze, BP Rubin, C Vernon, DS Hawkins, JD Bruckner, ... Cancer 103 (2), 339-348, 2005 | 254 | 2005 |
| Survival after recurrence of Ewing’s sarcoma family of tumors LM Barker, TW Pendergrass, JE Sanders, DS Hawkins Journal of clinical oncology 23 (19), 4354-4362, 2005 | 245 | 2005 |
| Thyroid cancer in the pediatric population VA Paulson, ER Rudzinski, DS Hawkins Genes 10 (9), 723, 2019 | 199 | 2019 |
| Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas DS Hawkins, SL Spunt, SX Skapek, COG Soft Tissue Sarcoma Committee Pediatric blood & cancer 60 (6), 1001-1008, 2013 | 192 | 2013 |
Erin RudzinskiSeattle Children's Hospital在 seattlechildrens.org 的电子邮件经过验证
